APA (7th ed.) Citation

Kapelios, C., Lainscak, M., Savarese, G., Laroche, C., Seferovic, P., Ruschitzka, F., . . . Gunes, H. (2019). Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry. European journal of heart failure, 21(11), 1383. https://doi.org/10.1002/ejhf.1532

Chicago Style (17th ed.) Citation

Kapelios, CJ, et al. "Sacubitril/valsartan Eligibility and Outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry." European Journal of Heart Failure 21, no. 11 (2019): 1383. https://doi.org/10.1002/ejhf.1532.

MLA (9th ed.) Citation

Kapelios, CJ, et al. "Sacubitril/valsartan Eligibility and Outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry." European Journal of Heart Failure, vol. 21, no. 11, 2019, p. 1383, https://doi.org/10.1002/ejhf.1532.